BreakBio

Curated by Signal

Developer of personalized cancer treatment through advanced AI technology

Overview

Developer of personalized cancer treatment through advanced AI technology. The company analyzes cancer cells from individual patients to identify multiple proteins present on those cells for personalized drug manufacturing.

Key facts

Founded: 2019
Headquarters: Miami, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

2 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

IntellxxDNA
Provider of clinical decision platform based on patient's genomic data
Life Sciences TechnologyAustin, United States
OBMedical
A fetal monitoring system
Life Sciences TechnologyNewberry, United States
Opticyte
Developing an oximeter for real-time monitoring of cellular oxygenation and perfusion
Life Sciences TechnologySeattle, United States

About BreakBio

What does BreakBio do?

Developer of personalized cancer treatment through advanced AI technology.

Where is BreakBio headquartered?

BreakBio is headquartered in Miami, United States.

When was BreakBio founded?

BreakBio was founded in 2019.

Which sector is BreakBio in?

BreakBio operates in Life Sciences Technology.

Who are BreakBio's competitors?

Companies similar to BreakBio include IntellxxDNA, OBMedical, and Opticyte.